Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Clinically significant carbapenemases: an update
Current Opinion in Infectious Diseases, 07/03/08
Walsh TR - Carbapenem resistance continues to increase both in number and into new species/strain types, but the therapeutic options remain woefully inadequate - a dilemma that will not improve in the foreseeable future.
Related Articles
Outbreak of carbapenem-resistant Acinetobacter baumannii carrying the carbapenemase OXA-23 in a German university medical centre
Journal of Medical Microbiology, 10/22/09
Relevance Score: 84%
Risk Factors and Clinical Impact of Klebsiella pneumoniae Carbapenemase–Producing K. pneumoniae
Infection Control and Hospital Epidemiology, 10/28/09
Relevance Score: 80%
Novel Genetic Environment of the Carbapenem-Hydrolyzing beta-Lactamase KPC-2 among Enterobacteriaceae in China
Antimicrobial Agents and Chemotherapy, 10/06/09
Relevance Score: 80%
Today in Antimicrobials...keeping you current
Receive free subspecialty "5-minute updates" via email
Antiretroviral Therapy With Heart
American Journal of Therapeutics, 11/25/09
Lopinavir Cerebrospinal Fluid Steady-State Trough Concentrations in HIV-Infected Adults
Annals of Pharmacotherapy, 11/25/09
Daptomycin Versus Other Antimicrobial Agents for the Treatment of Skin and Soft Tissue Infections: A Meta-Analysis
Annals of Pharmacotherapy, 11/25/09
Today in Drug Resistance...keeping you current
Receive free subspecialty "5-minute updates" via email
Risk Factors Associated with Methicillin Resistance among Staphylococcus aureus Infections in Veterans
Infection Control and Hospital Epidemiology, 11/25/09
Antiretroviral Drug-Resistant Mutations at Baseline and at Time of Failure of Antiretroviral Therapy in HIV Type 1-Coinfected TB Patients
AIDS Research and Human Retroviruses, 11/24/09
Protein Kinase A Activation Confers Resistance to Trastuzumab in Human Breast Cancer Cell Lines
Clinical Cancer Research, 11/20/09
Sponsor
Article Search
Sponsor


See Latest Articles


